Angiogenesis as a target for tumor treatment

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Angiogenesis, the formation of new blood vessels, is crucial for tumor growth, invasion, and metastasis.
• Antiangiogenic therapy offers a potential strategy to combat cancer by targeting this process.

Purpose of the Study:

• To review current strategies for inhibiting angiogenesis.
• To discuss the potential of antiangiogenic agents in cancer treatment.

Main Methods:

• Review of scientific literature on angiogenesis and antiangiogenic therapy.
• Analysis of findings from animal models and early clinical trials.

Main Results:

• Three main strategies for angiogenesis inhibition are identified: targeting angiogenic factors, inhibiting endothelial cell proliferation/migration, and disrupting vessel basement membrane synthesis.
• Angiogenesis inhibitors have demonstrated antitumor effects in preclinical animal models.

Conclusions:

• Antiangiogenic therapy is a promising approach for cancer treatment.
• Future optimal antiangiogenic therapy will likely involve long-term administration alongside conventional treatments like surgery, radiotherapy, and chemotherapy.